Veliparib Or Placebo In Newly Diagnosed Glioblastoma With MGMT

Test whether the experimental combination of ABT-888 (veliparib) combined with TMZ, compared to the control of placebo combined with TMZ, significantly extends overall survival in newly diagnosed GBM patients with tumor MGMT promoter hypermethylation.

September 25, 2015